Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • France
    • +34 96 390 53 10 Request Information
    • +34 96 390 53 10 Request Information
    FranceFrance
    • France
      • Part of brands: |
        • Nous Vous Guidons
          • Fertilité
          • Prevent inherited diseases
          • Worry-free pregnancy
        • Santé Reproductive
          • Specialists
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • POC
            • SAT
          • Patients
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • SAT
            • POC
        • À Propos de Nous
          • Igenomix Recherche
          • À propos d’Igenomix
        • Webinaires
        Genomics Precision Diagnostic > Ear, Nose, Throat Precision Panel > Branchiootorenal Syndrome Precision Panel

        Branchiootorenal Syndrome Precision Panel

        Branchiootorenal Syndrome (BOR) is a rare autosomal dominant disorder that disrupts the development of tissues in the neck and causes malformations of the ears and kidneys. It is characterized by branchial arch anomalies, hearing loss and renal anomalies ranging from hypoplasia to bilateral renal agenesis. 
        Overview
        Indication
        Clinical Utility
        Genes & Diseases
        Methodology
        References

        Overview

        • Branchiootorenal Syndrome (BOR) is a rare autosomal dominant disorder that disrupts the development of tissues in the neck and causes malformations of the ears and kidneys. It is characterized by branchial arch anomalies, hearing loss and renal anomalies ranging from hypoplasia to bilateral renal agenesis. Some individuals progress to end-stage renal disease (ESRD) later in life. It is a clinically heterogeneous disorder with variability in the presence, severity and type of branchial arch, otologic, audiologic and renal abnormality.  

        • The Igenomix Branchiootorenal Syndrome Precision Panel can be used to make an accurate and directed diagnosis ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved

        Indication

        • The Igenomix Branchiootorenal Syndrome Precision Panel  is indicated for those patients with a clinical suspicion or diagnosis with or without the following manifestations: 
          • Deafness 
          • Preauricular pits 
          • Auricular malformations 
          • Renal anomalies 
          • Branchial cleft cyst and fistula 
          • Long, narrow face 
          • Cleft palate 

        Clinical Utility

        The clinical utility of this panel is: 

        • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
        • Early initiation of treatment with a multidisciplinary team in the form surgical care of anatomic defects, surveillance for hearing impairment and renal function and prevention of complications such as infections. 
        • Risk assessment and genetic counselling of asymptomatic family members due to the autosomal dominant mode of inheritance.  
        • Improvement of delineation of genotype-phenotype correlation. 

        Genes & Diseases

        See all genes and diseases

        GENE 

        OMIM DISEASES 

        INHERITANCE* 

        % GENE COVERAGE (20X) 

        HGMD** 

        EYA1 

        Branchiootic Syndrome,
        Branchiootorenal
        Syndrome, 
        Otofaciocervical 
        Syndrome
         

        AD 

        100 

        197 of 199 

        SIX1 

        Branchiootic
         Syndrome,
        Branchiootorenal
        Syndrome,
        Autosomal
        Dominant
        Deafness
         

        AD 

        73 

        20 of 20 

        SIX5 

        Branchiootorenal
        Syndrome
         

        AD 

        93.16 

        11 of 11 

        TFAP2A 

        Branchiooculofacial 
        Syndrome 

        AD 

        98.61 

        37 of 37 

         * Inheritance: AD: Autosomal Dominant; AR: Autosomal Recessive; X: X linked; XLR: X linked Recessive; Mi: Mitochondrial; Mu: Multifactorial 

        ** HGMD: Number of clinically relevant mutations according to HGMD 

        Methodology

        References

        See scientific referrals

        Smith RJH. Branchiootorenal Spectrum Disorder. 1999 Mar 19 [Updated 2018 Sep 6]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1380/ 

        Nasir, S. B., Ladan, S. J., Bemu, A. N., & Jibrin, J. (2018). Branchiootorenal syndrome: A case report. The Nigerian postgraduate medical journal, 25(1), 60–62. https://doi.org/10.4103/npmj.npmj_203_17 

        Ječmenica, J., & Bajec-Opančina, A. (2015). Branchiootorenal and branchiooculofacial syndrome. The Journal of craniofacial surgery, 26(1), e30–e31. https://doi.org/10.1097/SCS.0000000000001268 

        Smith, R. (1999). Branchiootorenal Spectrum Disorder. In M. P. Adam (Eds.) et. al., GeneReviews®. University of Washington, Seattle. 

        Kochhar, A., Fischer, S. M., Kimberling, W. J., & Smith, R. J. (2007). Branchio-oto-renal syndrome. American journal of medical genetics. Part A, 143A(14), 1671–1678. https://doi.org/10.1002/ajmg.a.31561 

        Brophy, P., Alasti, F., Darbro, B., Clarke, J., Nishimura, C., & Cobb, B. et al. (2013). Genome-wide copy number variation analysis of a Branchio-oto-renal syndrome cohort identifies a recombination hotspot and implicates new candidate genes. Human Genetics, 132(12), 1339-1350. doi: 10.1007/s00439-013-1338-8 

        BROCHURE

        Download

        Request Information


        • reCAPTCHA demo: Simple page

        Fertilité

        Fertilité
        Éviter les maladies génétiques

        Test prénatal non-invasif

        Pour voir le certificat d'accréditation, l'annexe technique associée et la liste des tests accrédités, cliquez sur ce lien.

        Nos services

        Nos services
        Patients
        D'envoyer les échantillons
        Manuel d'utilisateur

        À propos d’Igenomix

        À propos d’Igenomix
        Igenomix dans le monde
        Quality
        Work with us

        SUIVRE IGENOMIX

          + 96 390 53 10
        Écrivez-nous
        • Argentina
        • Brazil
        • Canada
        • Chile
        • Colombia
        • Europe
        • France
        • Germany
        • India
        • Italy
        • Japan
        • Korea
        • Mexico
        • Perú
        • Russia
        • Spain
        • Taiwan
        • The Middle East
        • Turkey
        • United Kingdom
        • United States
        • Vietnam
        France

        [2021] © Igenomix Politique de confidentialité Politique de qualité Note juridique Politique de cookiesActualités et presse 

        Demander des informations


        • reCAPTCHA demo: Simple page

        • Nous Vous Guidons
          • Fertilité
          • Prevent inherited diseases
          • Worry-free pregnancy
        • Santé Reproductive
          • Specialists
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • POC
            • SAT
          • Patients
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • SAT
            • POC
        • À Propos de Nous
          • Igenomix Recherche
          • À propos d’Igenomix
        • Webinaires
        • France
        • +34 96 390 53 10 Request Information

        We are using cookies to give you the best experience on our website.

        You can find out more about which cookies we are using or switch them off in settings.

        France
        Powered by  GDPR Cookie Compliance
        Privacy Overview

        This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

        Strictly Necessary Cookies

        Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

        If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.